210 related articles for article (PubMed ID: 19650888)
21. Cell envelope defects of different capsule-null mutants in K1 hypervirulent Klebsiella pneumoniae can affect bacterial pathogenesis.
Tan YH; Chen Y; Chu WHW; Sham LT; Gan YH
Mol Microbiol; 2020 May; 113(5):889-905. PubMed ID: 31912541
[TBL] [Abstract][Full Text] [Related]
22. Effect in virulence of switching conserved homologous capsular polysaccharide genes from Klebsiella pneumoniae serotype K1 into K20.
Lin CL; Chen FH; Huang LY; Chang JC; Chen JH; Tsai YK; Chang FY; Lin JC; Siu LK
Virulence; 2017 Jul; 8(5):487-493. PubMed ID: 27565716
[TBL] [Abstract][Full Text] [Related]
23. Polyproline Peptide Aggregation with Klebsiella pneumoniae Extracellular Polysaccharides Exposes Biofilm Associated Bacteria.
Fleeman RM; Davies BW
Microbiol Spectr; 2022 Apr; 10(2):e0202721. PubMed ID: 35254120
[TBL] [Abstract][Full Text] [Related]
24. Klebsiella pneumoniae capsule polysaccharide impedes the expression of beta-defensins by airway epithelial cells.
Moranta D; Regueiro V; March C; Llobet E; Margareto J; Larrarte E; Garmendia J; Bengoechea JA
Infect Immun; 2010 Mar; 78(3):1135-46. PubMed ID: 20008534
[TBL] [Abstract][Full Text] [Related]
25. Genetic exchange of determinants for capsular polysaccharide biosynthesis between Klebsiella pneumoniae strains expressing serotypes K2 and K21a.
Ofek I; Kabha K; Athamna A; Frankel G; Wozniak DJ; Hasty DL; Ohman DE
Infect Immun; 1993 Oct; 61(10):4208-16. PubMed ID: 8104896
[TBL] [Abstract][Full Text] [Related]
26. Polysaccharide capsule-mediated resistance to opsonophagocytosis in Klebsiella pneumoniae.
Domenico P; Salo RJ; Cross AS; Cunha BA
Infect Immun; 1994 Oct; 62(10):4495-9. PubMed ID: 7927714
[TBL] [Abstract][Full Text] [Related]
27. The surface hydrophobicity and avirulent character of an encapsulated strain of Klebsiella pneumoniae.
Meno Y; Amako K
Microbiol Immunol; 1991; 35(10):841-8. PubMed ID: 1685761
[TBL] [Abstract][Full Text] [Related]
28. LPS O Antigen Plays a Key Role in Klebsiella pneumoniae Capsule Retention.
Singh S; Wilksch JJ; Dunstan RA; Mularski A; Wang N; Hocking D; Jebeli L; Cao H; Clements A; Jenney AWJ; Lithgow T; Strugnell RA
Microbiol Spectr; 2022 Aug; 10(4):e0151721. PubMed ID: 35913154
[TBL] [Abstract][Full Text] [Related]
29. Contribution of fucose-containing capsules in Klebsiella pneumoniae to bacterial virulence in mice.
Wu JH; Wu AM; Tsai CG; Chang XY; Tsai SF; Wu TS
Exp Biol Med (Maywood); 2008 Jan; 233(1):64-70. PubMed ID: 18156307
[TBL] [Abstract][Full Text] [Related]
30. Pathogenic potential of environmental Klebsiella pneumoniae isolates.
Struve C; Krogfelt KA
Environ Microbiol; 2004 Jun; 6(6):584-90. PubMed ID: 15142246
[TBL] [Abstract][Full Text] [Related]
31. Evaluating Different Virulence Traits of
Marcoleta AE; Varas MA; Ortiz-Severín J; Vásquez L; Berríos-Pastén C; Sabag AV; Chávez FP; Allende ML; Santiviago CA; Monasterio O; Lagos R
Front Cell Infect Microbiol; 2018; 8():30. PubMed ID: 29479519
[TBL] [Abstract][Full Text] [Related]
32. SitA contributes to the virulence of Klebsiella pneumoniae in a mouse infection model.
Sun WS; Syu WJ; Ho WL; Lin CN; Tsai SF; Wang SH
Microbes Infect; 2014 Feb; 16(2):161-70. PubMed ID: 24211873
[TBL] [Abstract][Full Text] [Related]
33. Protective Role of Kupffer Cells and Macrophages in Klebsiella pneumoniae-Induced Liver Abscess Disease.
Hoh CH; Tan YH; Gan YH
Infect Immun; 2019 Sep; 87(9):. PubMed ID: 31285251
[No Abstract] [Full Text] [Related]
34. Serotype K1 capsule, rather than magA per se, is really the virulence factor in Klebsiella pneumoniae strains that cause primary pyogenic liver abscess.
Yeh KM; Chang FY; Fung CP; Lin JC; Siu LK
J Infect Dis; 2006 Aug; 194(3):403-4; author reply 404-5. PubMed ID: 16826492
[No Abstract] [Full Text] [Related]
35. In vivo evolution of tigecycline-non-susceptible Klebsiella pneumoniae strains in patients: relationship between virulence and resistance.
Lin YT; Huang YW; Huang HH; Yang TC; Wang FD; Fung CP
Int J Antimicrob Agents; 2016 Nov; 48(5):485-491. PubMed ID: 27575728
[TBL] [Abstract][Full Text] [Related]
36. The intersection of capsule gene expression, hypermucoviscosity and hypervirulence in Klebsiella pneumoniae.
Walker KA; Miller VL
Curr Opin Microbiol; 2020 Apr; 54():95-102. PubMed ID: 32062153
[TBL] [Abstract][Full Text] [Related]
37. Role of lung epithelial cells in defense against Klebsiella pneumoniae pneumonia.
Cortés G; Alvarez D; Saus C; Albertí S
Infect Immun; 2002 Mar; 70(3):1075-80. PubMed ID: 11854185
[TBL] [Abstract][Full Text] [Related]
38. Klebsiella pneumoniae Reduces SUMOylation To Limit Host Defense Responses.
Sá-Pessoa J; Przybyszewska K; Vasconcelos FN; Dumigan A; Frank CG; Hobley L; Bengoechea JA
mBio; 2020 Sep; 11(5):. PubMed ID: 32994335
[No Abstract] [Full Text] [Related]
39. A promising bioconjugate vaccine against hypervirulent
Feldman MF; Mayer Bridwell AE; Scott NE; Vinogradov E; McKee SR; Chavez SM; Twentyman J; Stallings CL; Rosen DA; Harding CM
Proc Natl Acad Sci U S A; 2019 Sep; 116(37):18655-18663. PubMed ID: 31455739
[TBL] [Abstract][Full Text] [Related]
40. The KbvR Regulator Contributes to Capsule Production, Outer Membrane Protein Biosynthesis, Antiphagocytosis, and Virulence in Klebsiella pneumoniae.
Xu L; Wang M; Yuan J; Wang H; Li M; Zhang F; Tian Y; Yang J; Wang J; Li B
Infect Immun; 2021 Apr; 89(5):. PubMed ID: 33593891
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
